Altered Growth Phenotype of a Burkitt’s Lymphoma Line Following the Introduction and Stable Expression of the EBNA 2A Gene

Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells.

1987 • 735 citations

Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.

1987 • 397 citations

Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells

1987 • 376 citations

Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance.

1988 • 330 citations

Immortalized B lymphocytes produce B-cell growth factor

1984 • 204 citations

The activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cells.

1987 • 203 citations

Expression of the Epstein-Barr virus nuclear protein 2 in rodent cells

1986 • 78 citations

Control of human B-lymphocyte replication. II. Transforming Epstein-Barr virus exploits three distinct viral signals to undermine three separate control points in B-cell growth.

1986 • 65 citations

Soluble CD23 is released by B lymphocytes cycling in response to interleukin 4 and anti‐Bp50 (CDw40)

1988 • 63 citations

Triggering of B lymphocytes through CD23: epitope mapping and studies using antibody derivatives indicate an allosteric mechanism of signalling.

1987 • 43 citations

Protein kinase activity associated with Epstein-Barr virus-determined nuclear antigen

1981 • 20 citations